Summary
The present study was designed to assess the negative chronotropic and inotropic effects of 10 class I antiarrhythmic drugs, using isolated canine blood-perfused sinoatrial node and papillary muscle preparations. Each drug showed negative chronotropic and inotropic effects in a dose-related manner. The potency of the suppressive effect on the sinoatrial automaticity was in the order of aprindine, quinidine, flecainide, lidocaine, mexiletine, cibenzoline, disopyramide, procainamide, tocainide, and phenytoin, while the effect on the ventricular contraction was in the order of aprindine, flecainide, cibenzoline, lidocaine, mexiletine, disopyramide, tocainide, phenytoin, quinidine, and procainamide. The differences in the suppressive effects could not necessarily be explained by their subclassification, based either on action potential duration or kinetic properties of dissociation or association with sodium channels. On the other hand, we found a good correlation between the negative inotropic effects of class I drugs in this study and the canine antiarrhythmic plasma concentrations for the digitalis- and coronary ligation-induced ventricular arrhythmia models in our previous studies. However, the negative chronotropic effects of the drugs showed a poor correlation with the antiarrhythmic plasma drug concentrations. The data shown in this paper may provide a convenient guideline for predicting acute cardiosuppressive effects of antiarrhythmic drugs, especially in patients with reduced cardiac function.
Similar content being viewed by others
References
Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW (The CAST Investigators) (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 324:781–788
Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP (1996) Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348:7–12
Kodama I, Ogawa S, Inoue H, Kasanuki H, Kato T, Mitamura H, Hiraoka M, Sugimoto T. The Guideline Committee for Clinical Use of Antiarrhythmic Drugs in Japan (1999) Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian Gambit. Jpn Circ J 63:1–12
Members of the Sicilian Gambit (1994) Antiarrhythmic therapy. A pathophysiological approach. Futura, New York
Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit (1991) A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Circulation 84:1831–1851
Sugiyama A, Motomura S, Tamura K, Hashimoto K (1990) Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 53:97–110
Sugiyama A, Motomura S, Hashimoto K (1994) Utilization of an isolated, blood-perfused canine papillary muscle preparation as a model to assess efficacy and adversity of class I antiarrhythmic drugs. Jpn J Pharmacol 66:303–316
Hashimoto K, Sugiyama A, Haruno A, Matsuzaki T, Hirasawa A (1991) Effects of new antiarrhythmic drug TYB-3823 on canine ventricular arrhythmia models. J Cardiovasc Pharmacol 17:336–342
Hashimoto K, Haruno A, Matsuzaki T, Sugiyama A, Akiyama K (1991) Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness? Cardiovasc Drugs Ther 5:805–818
Endoh M, Hashimoto K (1970) Pharmacological evidence of autonomic nerve activities in canine papillary muscle. Am J Physiol 218:1459–1463
Kubota K, Hashimoto K (1973) Selective stimulation of the parasympathetic preganglionic nerve fibers in the excised and blood-perfused SA node preparation of the dog. Naunyn Schmiedebergs Arch Pharmacol 278:135–150
Sugiyama A, Motomura S, Hashimoto K (1991) Comparison of cardiovascular effects of a novel class Ic antiarrhythmic agent, NIK-244 with those of flecainide in isolated canine heart preparations cross-circulated with a donor dog. Jpn J Pharmacol 56:1–12
Sugiyama A, Xue YX, Hagihara A, Saitoh M, Hashimoto K (1996) Characterization of magnesium sulfate as an antiarrhythmic agent. J Cardiovasc Pharmacol Ther 1:243–254
Vaughan Williams EM (1984) A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 24:129–147
Josephson ME (1993) Sinus node function. In: Josephson ME (ed) Clinical cardiac electrophysiology: techniques and interpretations, 2nd ed. Lea & Febiger, Philadelphia, pp. 71–95
Satoh H, Nakajima T, Hashimoto K, Imai S (1981) Effects of lidocaine and procaine on the action potential of canine sinus nodal cells. Jpn Heart J 22:929–937
Satoh H, Hashimoto K (1984) Effects of lidocaine on membrane currents in rabbit sino-atrial node cells. Arch Int Pharmacodyn Ther 270:241–254
Satoh H, Hashimoto K (1986) Electrophysiological effects of procaine in rabbit sino-atrial node cells. Jpn J Pharmacol 40:83–93
Jalife J, Delmer M, Davidenko JM, Anumonwo JMB (1999) Basic cardiac electrophysiology for the clinician. Futura, New York
Honerjäger P, Loibl E, Steidl I, Schönsteiner G, Ulm K (1986) Negative inotropic effects of tetrodotoxin and seven class I antiarrhythmic drugs in relation to sodium channel blockade. Naunyn Schmiedebergs Arch Pharmacol 332:184–195
Ito K, Nakafuchi K, Taga A, Yorikane R, Koike H (1996) Possible involvement of altered Na+-Ca2+ exchange in negative inotropic effects of class I antiarrhythmic drugs on rabbit and rat ventricles. J Cardiovasc Pharmacol 27:355–361
Kihara Y, Inoko M, Hatakeyama N, Momose Y, Sasayama S (1996) Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium. J Cardiovasc Pharmacol 27:42–51
Nawada T, Tanaka Y, Hirai S, Hisatomi I, Hasegawa J, Kotake H, Mashiba H (1994) Evaluation of negative inotropic and antiarrhythmic effects of class I antiarrhythmic drugs. Int J Clin Pharmacol Ther 32:347–355
Harrison DC, Sprause JH, Morrow AG (1963) The antiarrhythmic properties of lidocaine and procaine amide. Circulation 28:486–491
Mullins LJ (1979) The generation of electric currents in cardiac fibers by Na/Ca exchange. Am J Physiol 236:C103–110
Himori N, Ono H, Taira N (1976) Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle. Jpn J Pharmacol 26:427–435
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sugiyama, A., Takehana, S., Kimura, R. et al. Negative chronotropic and inotropic effects of class I antiarrhythmic drugs assessed in isolated canine blood-perfused sinoatrial node and papillary muscle preparations. Heart Vessels 14, 96–103 (1999). https://doi.org/10.1007/BF02481749
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02481749